Physician profile
David Butler Sutherland
NPI 1235766742
$3,343.51
in general payments reported to CMS, 2019-2025
28 companies · $683 in 2025
The $683 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.42 · 2022: $362 · 2023: $1,170 · 2024: $1,100 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,650 · Education: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,649.77 |
| Education | $304.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $443.73 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Glaxosmithkline, LLC. | $373.12 | 2022-2023 | Arexvy, Bexsero |
| Abbott Laboratories | $325.29 | 2023-2025 | Ensite Precision, Ensite, Cardiomems |
| Amgen INC. | $238.64 | 2022-2023 | Repatha |
| Heartflow, INC. | $187.69 | 2024-2025 | |
| Boston Scientific Corporation | $154.85 | 2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.50 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $135.07 | 2023-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $125.00 | 2025 | |
| Irhythm Technologies, INC. | $123.54 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Circulation INC | $119.00 | 2024 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Inari Medical, INC. | $115.36 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $110.13 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $93.54 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $93.35 | 2024-2025 | Voquezna |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $92.58 | 2024-2025 | |
| Janssen Biotech, INC. | $62.62 | 2025 | Stelara, Simponi, Simponi Aria |
| Abiomed | $62.52 | 2024-2025 | Impella |
| Cvrx, INC. | $61.62 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.72 | 2025 | Jardiance |
| Celgene Corporation | $43.95 | 2023-2024 | Zeposia |
| Medtronic, INC. | $32.13 | 2022 | |
| Edwards Lifesciences Corporation | $30.54 | 2023 | Sapien 3 Ultra Resilia |
| Terumo Medical Corporation | $29.16 | 2023 | Tr Band, Angio-Seal, Glidesheath Slender |
| Mauna Kea Technologies, INC. | $27.42 | 2021 | |
| Getinge USA Sales, LLC | $26.52 | 2023 | Cardiosave Hybrid, Type B Plug |
| Kestra Medical Technology Services, INC. | $19.98 | 2024 | Assure Wcd |
| Bridgebio Pharma, INC. | $17.94 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sutherland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.